In large doses, lysergic acid diethylamide (LSD) can repair damaged neurons in the brain, and reveal new ways of seeing the world. In small doses, microdosers chase the effects of the drug on ...
NEW YORK, May 26, 2021 /CNW/ — MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today the publication of the first pharmacogenetic data on LSD to ...
NEW YORK, May 26, 2021 /CNW/ -- MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today the publication of the first pharmacogenetic data on LSD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback